{
  "id": 20208834,
  "title": "Which Healthcare ETF Is Best for the Long Term: State Street’s XPH or Invesco’s PBE?",
  "url": "https://urgent.news/2026/11/15/which-healthcare-etf-is-best-for-the-long-term-state-streets-xph-or-20208834",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-11-15T17:11:43.000Z",
  "source": {
    "name": "Nasdaq Markets",
    "slug": "nasdaq-markets",
    "url": "https://www.nasdaq.com/articles/which-healthcare-etf-best-long-term-state-streets-xph-or-invescos-pbe"
  },
  "original_language": "en",
  "account": null,
  "summary": "Key PointsState Street SPDR S&P Pharmaceuticals ETF provides a more diversified and lower-cost entry to the healthcare sector than its Invesco counterpart.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "Motley Fool",
        "title": "Which Healthcare ETF Is Best for the Long Term: State Street’s XPH or Invesco’s PBE?",
        "url": "https://urgent.news/2026/11/15/which-healthcare-etf-is-best-for-the-long-term-state-streets-xph-or",
        "published": "2026-11-15T16:51:43.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}